The TJX Companies, Inc. (LON:0LCE)

CTI BioPharma Statistics

Total Valuation

LON:0LCE has a market cap or net worth of GBP 106.12 billion. The enterprise value is 112.77 billion.

Market Cap	106.12B
Enterprise Value	112.77B

Important Dates

The next estimated earnings date is Wednesday, August 20, 2025.

Earnings Date	Aug 20, 2025
Ex-Dividend Date	May 15, 2025

Share Statistics

Current Share Class	1.12B
Shares Outstanding	n/a
Shares Change (YoY)	-1.37%
Shares Change (QoQ)	-0.53%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.11B

Valuation Ratios

The trailing PE ratio is 29.21 and the forward PE ratio is 27.39.

PE Ratio	29.21
Forward PE	27.39
PS Ratio	2.48
PB Ratio	16.59
P/TBV Ratio	16.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.45, with an EV/FCF ratio of 39.69.

EV / Earnings	31.04
EV / Sales	2.62
EV / EBITDA	13.45
EV / EBIT	23.79
EV / FCF	39.69

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 1.54.

Current Ratio	1.16
Quick Ratio	0.45
Debt / Equity	1.54
Debt / EBITDA	1.18
Debt / FCF	3.46
Interest Coverage	83.71

Financial Efficiency

Return on equity (ROE) is 60.36% and return on invested capital (ROIC) is 18.81%.

Return on Equity (ROE)	60.36%
Return on Assets (ROA)	12.75%
Return on Invested Capital (ROIC)	18.81%
Return on Capital Employed (ROCE)	29.85%
Revenue Per Employee	117,771
Profits Per Employee	9,981
Employee Count	364,000
Asset Turnover	1.85
Inventory Turnover	5.94

Taxes

In the past 12 months, LON:0LCE has paid 1.21 billion in taxes.

Income Tax	1.21B
Effective Tax Rate	24.99%

Stock Price Statistics

The stock price has increased by +12.21% in the last 52 weeks. The beta is 0.88, so LON:0LCE's price volatility has been lower than the market average.

Beta (5Y)	0.88
52-Week Price Change	+12.21%
50-Day Moving Average	125.46
200-Day Moving Average	123.07
Relative Strength Index (RSI)	49.58
Average Volume (20 Days)	1,052

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.36

Income Statement

In the last 12 months, LON:0LCE had revenue of GBP 42.87 billion and earned 3.63 billion in profits. Earnings per share was 3.20.

Revenue	42.87B
Gross Profit	13.07B
Operating Income	4.72B
Pretax Income	4.84B
Net Income	3.63B
EBITDA	5.58B
EBIT	4.72B
Earnings Per Share (EPS)	3.20

Balance Sheet

The company has 3.20 billion in cash and 9.83 billion in debt, giving a net cash position of -6.62 billion.

Cash & Cash Equivalents	3.20B
Total Debt	9.83B
Net Cash	-6.62B
Net Cash Per Share	n/a
Equity (Book Value)	6.40B
Book Value Per Share	5.73
Working Capital	1.33B

Cash Flow

In the last 12 months, operating cash flow was 4.34 billion and capital expenditures -1.50 billion, giving a free cash flow of 2.84 billion.

Operating Cash Flow	4.34B
Capital Expenditures	-1.50B
Free Cash Flow	2.84B
FCF Per Share	n/a

Margins

Gross margin is 30.48%, with operating and profit margins of 11.02% and 8.47%.

Gross Margin	30.48%
Operating Margin	11.02%
Pretax Margin	11.30%
Profit Margin	8.47%
EBITDA Margin	13.01%
EBIT Margin	11.02%
FCF Margin	6.63%

Dividends & Yields

This stock pays an annual dividend of 1.21, which amounts to a dividend yield of 0.96%.

Dividend Per Share	1.21
Dividend Yield	0.96%
Dividend Growth (YoY)	10.32%
Years of Dividend Growth	4
Payout Ratio	35.03%
Buyback Yield	1.37%
Shareholder Yield	2.32%
Earnings Yield	3.42%
FCF Yield	2.68%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 7, 2018. It was a forward split with a ratio of 2.

Last Split Date	Nov 7, 2018
Split Type	Forward
Split Ratio	2

Scores

LON:0LCE has an Altman Z-Score of 6.24 and a Piotroski F-Score of 5.

Altman Z-Score	6.24
Piotroski F-Score	5